CD8A and cancer: Programmed cell death ligand 1 (PD-L1) on tumor cells or tumor derived exosomes binds programmed cell death 1 (PD-1) on T cells and efficiently stimulates cytotoxic CD8+T cell malfunctioning and apoptosis, allowing cancer cells to escape from the immune attack [17, 40, 41].